The role of regional chemotherapy in the management of extremity soft tissue malignancies

被引：10

作者：

Smith, H. G. ^{[1
]}

Hayes, A. J. ^{[1
]}

机构：

[1] Royal Marsden Hosp NHS Fdn Trust, Sarcoma & Melanoma Unit, Acad Dept Surg, London, England

来源：

EJSO | 2016年 / 42卷 / 01期

关键词：

Isolated limb perfusion; Isolated limb infusion; In-transit melanoma; Soft tissue sarcoma; ISOLATED LIMB PERFUSION; TUMOR-NECROSIS-FACTOR; MERKEL CELL-CARCINOMA; TERM-FOLLOW-UP; FACTOR-ALPHA; INTERFERON-GAMMA; ADVANCED MELANOMA; PHASE-I; INTRAARTERIAL TEMOZOLOMIDE; HYPERTHERMIC PERFUSION;

D O I：

10.1016/j.ejso.2015.08.165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Regional chemotherapy involves the targeted delivery of high dose chemotherapy to an affected area. In the limbs, the two main methods employed are isolated limb perfusion (ILP) and isolated limb infusion (ILI), with advantages and disadvantages to each technique. The aim of this review was to clarify the roles of each technique in the management of locally advanced soft tissue malignancies of the extremities. Methods: Relevant articles were identified from a comprehensive literature search using the PubMed database. Keywords included isolated limb perfusion, isolated limb infusion, in-transit melanoma and sarcoma. No restrictions on publication date were used. Results: Regional chemotherapy may be used to secure local control in a range of soft tissue malignancies not amenable to standard excision and is increasingly used as an induction treatment in soft tissue sarcoma. Though both ILI and ILP are well established in the management of in-transit melanoma, ILP should be preferentially used in soft tissue sarcoma. Conclusion: Regional chemotherapy is an effective treatment for locally advanced extremity malignancies and the technique used should be tailored to patient and tumour factors. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：7 / 17

页数：11

共 92 条

[11] Extra-abdominal primary fibromatosis:: Aggressive management could be avoided in a subgroup of patients [J].

Bonvalot, S. ;

Eldweny, H. ;

Haddad, V. ;

Rimareix, F. ;

Missenard, G. ;

Oberlin, O. ;

Vanel, D. ;

Terrier, P. ;

Blay, J. Y. ;

Le Cesne, A. ;

Le Pechoux, C. .

EJSO, 2008, 34 (04) :462-468

[12] Limb salvage with isolated perfusion for soft tissue sarcoma:: could less TNF-α be better? [J].

Bonvalot, S ;

Laplanche, A ;

Lejeune, F ;

Stoeckle, E ;

Le Péchoux, C ;

Vanel, D ;

Terrier, P ;

Lumbroso, J ;

Ricard, M ;

Antoni, G ;

Cavalcanti, A ;

Robert, C ;

Lassau, N ;

Blay, JY ;

Le Cesne, A .

ANNALS OF ONCOLOGY, 2005, 16 (07) :1061-1068

[13] Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient [J].

Bonvalot, Sylvie ;

Rimareix, Francoise ;

Causeret, Sylvain ;

Le Pechoux, Cecile ;

Boulet, Berenice ;

Terrier, Philippe ;

Le Cesne, Axel ;

Muret, Jane .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) :3350-3357

[14]

Bonvalot S, 2009, B CANCER, V96, P103, DOI [10.1684/bdc.2008.0803, 10.1684/bdc.2009.0803]

[15] A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity [J].

Brady, Mary S. ;

Brown, Karen ;

Patel, Ami ;

Fisher, Charles ;

Marx, Will .

ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (08) :1123-1129

[16] HYPERTHERMIC ISOLATED LIMB PERFUSION FOR MALIGNANT-MELANOMA - RESPONSE AND SURVIVAL [J].

BRYANT, PJ ;

BALDERSON, GA ;

MEAD, P ;

EGERTON, WS .

WORLD JOURNAL OF SURGERY, 1995, 19 (03) :363-368

[17] Electrochemotherapy for disseminated superficial metastases from malignant melanoma [J].

Campana, L. G. ;

Valpione, S. ;

Mocellin, S. ;

Sundararajan, R. ;

Granziera, E. ;

Sartore, L. ;

Chiarion-Sileni, V. ;

Rossi, C. R. .

BRITISH JOURNAL OF SURGERY, 2012, 99 (06) :821-830

[18] Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis [J].

Caraco, Corrado ;

Mozzillo, Nicola ;

Marone, Ugo ;

Simeone, Ester ;

Benedetto, Lucia ;

Di Monta, Gianluca ;

Di Cecilia, Maria Luisa ;

Botti, Gerardo ;

Ascierto, Paolo Antonio .

BMC CANCER, 2013, 13

[19] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].

CARSWELL, EA ;

OLD, LJ ;

KASSEL, RL ;

GREEN, S ;

FIORE, N ;

WILLIAMSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670

[20] Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group trial Z0020 [J].

Cornett, Wendy R. ;

McCall, Linda M. ;

Petersen, Rebecca P. ;

Ross, Merrick I. ;

Briele, Henry A. ;

Noyes, R. Dirk ;

Sussman, Jeffrey J. ;

Kraybill, William G. ;

Kane, John M., III ;

Alexander, H. Richard ;

Lee, Jeffrey E. ;

Mansfield, Paul F. ;

Pingpank, James F. ;

Winchester, David J. ;

White, Richard L., Jr. ;

Chadaram, Vijaya ;

Herndon, James E., II ;

Fraker, Douglas L. ;

Tyler, Douglas S. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4196-4201

← 1 2 3 4 5 6 7 8 9 10 →